Lv6
2290 积分 2025-02-26 加入
Recent discoveries of Sino-Caucasian differences in the genetics of phaeochromocytomas and paragangliomas
17天前
已关闭
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
23天前
已完结
177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial
23天前
已完结
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
1个月前
已完结
Belzutifan for Advanced Pheochromocytoma or Paraganglioma
2个月前
已完结
Belzutifan for Advanced Pheochromocytoma or Paraganglioma
2个月前
已完结
新型FAP靶向示踪剂64Cu-FAPI-XT117在恶性实体肿瘤中的初步临床研究：与18F-FDG的对比研究
4个月前
已完结
Experimental-histological studies on the labyrinth; supplementary remarks concerning the phenomena of compression observed on intravital and postmortal fixation
4个月前
已完结
HER2 testing: evolution and update for a companion diagnostic assay
4个月前
已完结
皖公网安备34019202002308
